Glibenclamide 5 Mg (Generic)
45.00$ – 70.00$Price range: 45.00$ through 70.00$
Product Overview Glibenclamide 5 Mg is a widely prescribed oral antidiabetic medication used in the management of Type 2 diabetes mellitus. Manufactured by Aristo Pharmaceuticals Pvt. Ltd. , this generic formulation delivers a consistent 5 mg dose o
| Active Ingredients | Glibenclamide |
|---|---|
| Delivery Time | 6 To 15 days |
| Indication | Type 2 diabetes |
| Manufacturer | Aristo Pharmaceuticals Pvt. Ltd. |
| Packaging | 10 tablets in 1 strip |
| Strength | 5mg |
- Delivery & Return
Delivery
- If your order is damaged, delayed, or partially received, we will dispatch a new package or issue a full refund. For partial orders, you will only be charged for the items received, with the remaining balance refunded.
- Average shipping time via EMS is 1-4 weeks. Delivery may take up to 30 days due to postal disruptions from weather or natural disasters.
- If your package is held, delayed, or returned, please inform us at support@genariccurerx.com, and we will resolve the issue promptly.
- For any questions or queries regarding your order, contact us at support@genariccurerx.com.
Return & Refund
- We will reship or refund any lost orders if contacted within 8 weeks of the ship date. No reshipments or refunds after 8 weeks.
- We will replace undelivered orders if:
- An additional 7 days have passed since the standard delivery time.
- The shipping address provided is correct.
- For incorrect addresses, you will be charged for the replacement. If the original order is returned, we will process a refund, which may take time due to unpaid return postage.
Help
- Give us a shout if you have any other questions and/or concerns.
- Email: support@genariccurerx.com
- Phone: +91 9157057042
- Ask a Question
| Pack Size | Price | Quantity | |
|---|---|---|---|
| 120 Tablet/s | 45.00$ | ||
| 180 Tablet/s | 58.00$ | ||
| 300 Tablet/s | 70.00$ |
Product Overview
Glibenclamide 5 Mg is a widely prescribed oral antidiabetic medication used in the management of Type 2 diabetes mellitus. Manufactured by Aristo Pharmaceuticals Pvt. Ltd., this generic formulation delivers a consistent 5 mg dose of glibenclamide in a convenient strip of 10 tablets. The product is available in pack sizes of 120, 180, and 300 tablets, offering flexibility for patients and clinicians seeking reliable blood‑glucose control. Shipping typically takes 6 to 15 days, ensuring a timely supply for ongoing therapy.
What is Glibenclamide
Glibenclamide, also known as glyburide in some regions, belongs to the sulfonylurea class of drugs. It functions primarily by stimulating the pancreatic beta‑cells to release insulin, thereby lowering fasting and post‑prandial glucose levels. The active ingredient is Glibenclamide, and the medication is indicated for adults with Type 2 diabetes when diet and exercise alone are insufficient. For detailed scientific background, refer to the National Center for Biotechnology Information.
Uses and Benefits
The primary use of Glibenclamide 5 Mg is to improve glycemic control in patients with Type 2 diabetes. Clinical studies have demonstrated that regular use can reduce HbA1c by approximately 0.5 to 1.0 % when combined with lifestyle modifications. Benefits include:
- Effective reduction of fasting plasma glucose.
- Convenient once‑daily dosing that supports adherence.
- Cost‑effective generic alternative to brand‑name sulfonylureas.
- Available in multiple pack sizes to suit individual treatment plans.
For additional information on diabetes management, consult the MedlinePlus database.
How It Works
Glibenclamide acts by binding to the sulfonylurea receptor (SUR1) on the surface of pancreatic beta‑cells. This interaction closes ATP‑sensitive potassium channels, leading to membrane depolarization and subsequent calcium influx, which triggers insulin secretion. The released insulin enhances peripheral glucose uptake and suppresses hepatic glucose production. The mechanism is well documented in peer‑reviewed literature, including reviews indexed by PubMed.
Dosage Guidelines
Dosage of Glibenclamide must be individualized by a qualified healthcare professional. Typical initiation is a low dose, often 2.5 mg once daily, which may be titrated based on glycemic response and tolerability. The drug is intended for oral administration and should be taken with breakfast or the first main meal of the day to minimize gastrointestinal discomfort. Patients should never adjust their dose without medical supervision. For comprehensive prescribing information, see the FDA drug database.
Side Effects
Like all medications, Glibenclamide can cause adverse effects. Most are mild and transient, but some may require medical attention. Common side effects include:
- Hypoglycemia (low blood sugar) – the most serious risk.
- Nausea, vomiting, or abdominal discomfort.
- Headache or dizziness.
- Skin rash or itching.
Rare but severe reactions such as hepatic dysfunction or severe hypersensitivity have been reported. If any sign of hypoglycemia occurs (e.g., sweating, tremors, confusion), immediate carbohydrate intake and medical evaluation are recommended. For a complete safety profile, refer to the Drugs.com monograph.
Warnings and Precautions
Before initiating therapy, healthcare providers should assess:
- Renal or hepatic impairment, which may necessitate dose adjustment.
- History of hypoglycemia or cardiac events.
- Concurrent use of other antidiabetic agents that increase hypoglycemia risk.
Glibenclamide is contraindicated in patients with Type 1 diabetes, diabetic ketoacidosis, or severe renal disease. Pregnant or breastfeeding women should only use the medication under strict medical supervision. Store the tablets in a dry place, away from direct sunlight, and keep out of reach of children. For official prescribing information, consult the National Institutes of Health resources.
Frequently Asked Questions
- Can Glibenclamide be used alongside insulin therapy? Yes, but only under close medical supervision, as the combination increases hypoglycemia risk.
- How long does it take to see a reduction in blood glucose levels? Most patients notice a modest decline within 1–2 weeks, with maximal effect observed after several weeks of consistent use.
- Is the medication safe for elderly patients? Caution is advised; lower initial doses are recommended due to increased sensitivity and potential for renal function decline.
- What should I do if I miss a dose? Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose; do not double up.
- Are there dietary restrictions while taking Glibenclamide? No specific diet is required, but maintaining regular meals and monitoring carbohydrate intake helps prevent glucose fluctuations.
Related Products
- Okamet 500 Mg (Metformin)
- Megapen 250 mg (Ampicillin/Cloxacillin)
- Monocef Injection 2gm (Ceftriaxone)
- Monocef Injection 1gm (Ceftriaxone)
- Monocef Injection 500mg (Ceftriaxone)
- Monocef Injection 250mg (Ceftriaxone)
- Mikacin injection 500mg (Amikacin)
- Mikacin injection 250mg (Amikacin)
- Monocef Injection (Ceftriaxone)
- Mikacin injection 100mg (Amikacin)
- Mikacin injection (Amikacin)
- Amikacin injection 500mg (Generic)
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |
- Acidity
- Addiction
- Allergy
- Anal fissure
- Anemia
- Anti Fungal
- Anti Rejection Drugs
- Anti Worm
- Antibiotic
- Arthritis
- Benign Prostatic Hyperplasia
- Bipolar Disoder
- Blood
- Blood Cancer
- Blood Sugar
- Brain Tumor
- Breast Cancer
- Brest Cancer
- Buy Sildenafil
- Buy Tadalafil
- Chickenpox
- Chronic Idiopathic Myelofibrosis
- Chronic Myeloid Leukemia
- Colon
- Colon Cancer
- Constipation
- Crohn’s Disease
- Dandruff
- Device
- Diabetes Care
- Diarrhoea
- Dry Eyes
- Eye Care
- Eye Examination
- Eye Infection
- Eye Lashes
- Eye Pain
- Eyes/Ear Care
- Facial Hirsutism
- Female Generic Viagra
- Fever
- Fever Care
- Fungal Infection
- Gallbladder Stones
- Gastrointestinal
- Hair Care
- Heart Attack
- Heart Care
- Hepatic Encephalopathy
- Hepatitis B
- Hepatitis C
- Herbal Products
- HIV infection
- HIV-Aids
- Hodgkin’s Disease
- Hormonal Disease
- Hyperpigmentation
- Hyperthyroidism
- Immunity Booster
- Improves The Immune System
- Insomnia
- Intermittent Claudication
- Irritable Bowel Syndrome
- Ivermectin
- Kidney Care
- kidney/Liver
- Leprosy
- Life Saving Drugs
- Liver Care
- Liver Disease
- Local Anesthesia
- Low Thyroid Hormone
- Magnesium Deficiency
- Malaria
- Melasma
- Men's Health
- Motion Sickness
- Mouth Sores
- Multiple Myeloma
- Multiple sclerosis
- Muscle pain
- Muscle Relaxation
- Muscle Spasms
- Nasal Blocked
- Nausea
- Neurology Drugs
- Nutrition Care
- Nutritional Deficiencies
- Oedema Care
- Ortho Care
- Osteoarthritis
- Other
- Other Drugs
- Overactive bladder (OAB)
- Pain
- Pain Relief
- Peptides
- Peripheral Vascular
- Prevention of Rabies
- Prostate cancer
- Respiratory
- Rheumatoid Arthritis
- Scars
- Semaglutide
- Skin Care
- Skin Light
- Thyroids Care
- Unknown
- Urinary Incontinence
- Viral Care
- Vitamin Deficiency
- Wegovy
- Weight Loss
- Women Care
Related Products
Product Overview Metformin Sustained Release 500 Mg (Generic) is a prescription oral antihyperglycemic agent formulated for the management of type 2 diabetes mellitus. Produced by USV Pvt Ltd, this tablet belongs to the biguanide class and delivers t
In stock
Product Overview
Pioglitazone 30 mg is a generic oral antidiabetic produced by USV Pvt. Ltd. Each tablet delivers 30 mg of pioglitazone, a thiazolidinedione that improves insulin sensitivity. The medication is supplied in strips containing 10 tab
In stock
Product Overview
Voglibose 0.2 mg is a generic oral antidiabetic medication manufactured by Abbott India Pvt Ltd. It belongs to the class of alpha-glucosidase inhibitors and is specifically indicated for the treatment of type 2 diabetes mellitus. T
In stock
Product Overview Imeglimin 500 Mg is a prescription oral medication formulated for the management of type 2 diabetes mellitus. Manufactured by Zydus Lifesciences, the product is supplied in a convenient strip containing ten tablets, each delivering a
In stock
Product Overview Repaglinide 1 mg is a generic oral antidiabetic medication supplied by Novo Nordisk India. Each strip contains 15 tablets, and the product is available in pack sizes of 30, 60, or 90 tablets. It is indicated for the treatment of type
In stock
Product Overview
Sitagliptin 25 Mg, supplied by Sun Pharmaceutical Industries Ltd, is a prescription oral medication indicated for the management of type 2 diabetes mellitus. Each strip contains ten tablets, each delivering a precise 25 mg dose o
In stock
Product Overview Voglibose 0.3 mg tablets, produced by Abbott India Pvt Ltd, belong to the class of alpha‑glucosidase inhibitors and are formulated for the control of postprandial glucose excursions in patients with type 2 diabetes mellitus. Each str
In stock
Product Overview Sitagliptin 100 Mg (Generic) is an oral antidiabetic medication indicated for the management of type 2 diabetes mellitus. Manufactured by Sun Pharmaceutical Industries Ltd, this product is supplied in packs containing 10 tablets per
In stock
Product Overview
Sitagliptin 50 mg is a widely prescribed oral antihyperglycemic agent used in the treatment of Type 2 diabetes mellitus. The medication is produced by Sun Pharmaceutical Industries Ltd, a globally recognized manufacturer with a s
In stock
Product Overview
Metformin 850 mg is a widely prescribed oral hypoglycemic agent used in the management of Type 2 diabetes mellitus. Manufactured by USV Pvt Ltd, this generic formulation delivers a consistent 850 mg dose of metformin in each tabl
In stock
Product Overview Miglitol 25 mg is a generic oral antidiabetic produced by Glenmark Pharmaceuticals Ltd. Each strip holds fifteen film‑coated tablets, each containing 25 mg of the active ingredient. The product is offered in pack sizes of 30, 60, and
In stock
Product Overview Repaglinide 2 mg (Generic) is a prescription oral antidiabetic medication indicated for the management of type 2 diabetes mellitus. Manufactured by Novo Nordisk India this product is supplied in a strip containing 15 tablets each con
In stock



Reviews
There are no reviews yet.